ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,051.09
0.00%
US Tech 100
21,191.20
0.62%
Dow Jones
43,828.06
-0.20%
Brent Oil
74.135
0.00%
Bitcoin
101,882.84
0.42%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Tango Therapeutics Inc (TNGX) Quote

Tango Therapeutics Inc

Tango Therapeutics Inc (TNGX)

NASDAQ
3.06
0.21
(7.37%)
Closed December 14 4:00PM
Delayed by 15 minutes
3.06
-0.005
(-0.16%)
After Hours: 7:23PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
3.06
Bid
2.91
Ask
3.05
Volume
2,799,690
2.70 Day's Range 3.075
2.70 52 Week Range 13.005
Market Cap
328.699M
Previous Close
2.85
Open
2.85
Last Trade
35
@
3.05
Last Trade Time
Financial Volume
$ 8,095,416
VWAP
2.8915
Average Volume (3m)
1,856,750
Shares Outstanding
107,417,818
Dividend Yield
-
PE Ratio
-3.23
Earnings Per Share (EPS)
-0.95
Revenue
36.53M
Net Profit
-101.74M

About Tango Therapeutics Inc

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.tangotx.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Tango Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TNGX. The last closing price for Tango Therapeutics was $2.85. Over the last year, Tango Therapeutics shares have traded in a share price range of $ 2.70 to $ 13.005.

Tango Therapeutics currently has 107,417,818 shares outstanding. The market capitalization of Tango Therapeutics is $306.14 million. Tango Therapeutics has a price to earnings ratio (PE ratio) of -3.23.

Ask ADVFN Intelligence (AI)

TNGX Latest News

More News

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

December 03 2024
Business Wire

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...

November 27 2024
Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

November 20 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 18 2024
Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

November 07 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

November 06 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 06 2024
Edgar (US Regulatory)

Form 8-K - Current report

November 06 2024
Edgar (US Regulatory)

Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

– Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program moving into full development with multiple combination studies – – Clinical collaboration...

November 06 2024
Business Wire

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program

– TNG462 demonstrated durable clinical activity across multiple tumor types, including non-small cell lung cancer (NSCLC) and pancreatic cancer, in ongoing phase 1/2 clinical trial, moving into...

November 06 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.34-103.43.62.811611323.14571397CS
4-0.725-19.15455746373.7854.222.814704993.66188943CS
12-5.38-63.74407582948.448.582.718567504.50430036CS
26-4.49-59.47019867557.5512.0152.713515136.33963683CS
52-6.49-67.95811518329.5513.0052.79883357.27959469CS
156-7.98-72.282608695711.0413.032.476971767.26641056CS
260-6.55-68.15816857449.6118.842.476473107.48239864CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WKEYWISeKey International Holdings AG
$ 7.84
(139.02%)
75.53M
IPHAInnate Pharma SA
$ 3.00
(93.55%)
13.59M
AVLDirexion Daily AVGO Bull 2X Shares
$ 33.67
(48.92%)
658.55k
LOOPLoop Industries Inc
$ 1.8092
(47.09%)
82.56M
AVGXDefiance Daily Target 2X Long AVGO ETF
$ 31.49
(46.67%)
3.55M
RPTXRepare Therapeutics Inc
$ 1.765
(-55.54%)
4.7M
INOInovio Pharmaceuticals Inc New
$ 2.31
(-38.56%)
9.86M
XXII22nd Century Group Inc
$ 0.048
(-34.69%)
42.23M
FLGCFlora Growth Corporation
$ 1.30
(-34.34%)
4.14M
WTOUTime Limited
$ 0.281
(-32.74%)
3.79M
NVDANVIDIA Corporation
$ 134.25
(-2.25%)
231.23M
SOUNSoundHound AI Inc
$ 16.905
(23.66%)
159.56M
TRUGTruGolf Holdings Inc
$ 0.6794
(30.93%)
141.89M
RGTIRigetti Computing Inc
$ 7.155
(19.85%)
124.45M
AVGOBroadcom Inc
$ 224.80
(24.43%)
121.33M

TNGX Discussion

View Posts
Monksdream Monksdream 5 months ago
TNGX under $10
👍️0
Monksdream Monksdream 7 months ago
TNGX under $10
👍️0
bikaver bikaver 1 year ago
Stopped out with small loss.
👍️0
bikaver bikaver 1 year ago
TNGX......Holding up well, but will tumble soon.
👍️0
bikaver bikaver 1 year ago
TNGA.....short @ 8.60 This is the strength that I wanted to see!
👍️0
bikaver bikaver 1 year ago
TNGX.....Studying the TNGX chart this evening. I'll short it at a good sign of strength if the opportunity presents itself tomorrow.
👍️0
SmokeSignals SmokeSignals 1 year ago
up $4>H.C. Wainwright Reaffirms Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Barclays Releases a Buy Rating on Tango Therapeutics (TNGX)AUGUST 8, 2023TIPRANKS
Goldman Sachs Keeps Their Buy Rating on Tango Therapeutics (TNGX)AUGUST 7, 2023TIPRANKS
Tango Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business HighlightsAUGUST 7, 2023TIPRANKS
Tango Therapeutics reports Q2 EPS (23c), consensus (34c)AUGUST 7, 2023TIPRANKS
👍️0

Your Recent History

NASDAQ
TNGX
Tango Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved